Paul Oldham
Analyst · Needham & Company
Thank you, Yuval and good morning everyone. Total revenue for the fourth quarter of 2019 was $338 million, up from $175 million in Q3, which only included a partial month of Artesyn. Excluding Artesyn, organic revenue grew 18% sequentially and 3% year-over-year to $159 million. On a pro forma basis, including a full quarter of Artesyn revenue in prior periods, Q4 revenue grew 17% sequentially and 8.5% year-over-year driven by strong growth in semiconductor equipment and data center computing. For the full year 2019, we recognized record revenues of $789 million, reflecting 9.7% growth over 2018. Excluding Artesyn, our 2019 revenues were $569 million, down 21% from 2018 primarily due to the downturn in the semiconductor equipment market in the first three quarters of the year and ongoing macro weakness affecting our industrial products.Before I talk about our sales by markets, I want to note that my forward-looking comments for Q1 reflect our demand outlook, not revenue. I will cover our revenue outlook at the end of my comments given the potential impact on our operations of the evolving situation in China. Semiconductor equipment revenue for Q4 was $125 million, up 30% from last quarter and 16% year-over-year. On a pro forma basis, semi revenues were up 28% sequentially driven by 41% sequential growth in semi product sales. We saw continued growth in OEM demand driven by investment in foundry logic, some recovery in memory and the incremental contribution from our prior design wins. For the year, semi revenues were $403 million, down from $534 million last year.Looking to Q1, we expect demand in semi to grow sequentially in the mid-teens with growth from both foundry logic and memory applications. This outlook would represent year-over-year growth of greater than 45%. Revenue from industrial and medical markets was $97 million, up significantly sequentially and year-over-year due to the addition of Artesyn. On a pro forma basis, revenues were down less than 1% sequentially. During the quarter, we saw continued macro weakness in several of our industrial sectors, but we were able to largely offset these macro trends with shipments of specific programs resulting from prior design wins for both existing and new embedded power products.Artesyn products contributed $61 million of sales into the industrial and medical markets in Q4, which was up 3.3% from Q3 on a pro forma basis. For the full year, industrial and medical revenues were $246 million, up from $185 million in 2018. Excluding Artesyn, 2019 revenues were $169 million, with a decline due mainly to weaker demand in flat pound display, consumer electronics related decorative and optical coatings, and glass manufacturing in Europe and China. Looking to Q1, we expect demand from this market to be down sequentially on normal seasonality and the absence of the one-time projects in Q4.Data center computing revenue was $78 million with significant growth versus the partial quarter recorded in Q3. On a pro forma basis, revenues were up about 70% sequentially and 27% year-over-year based on the significant share gains, particularly in hyperscale that Yuval discussed earlier. In Q1, we expect demand to show modest to sequential growth from the record Q4 with continued strength in hyperscale offset by seasonally lower demand from enterprise computing customers.Telecom and networking was $38.5 million. On a pro forma basis, revenues declined about 20% from Q3 which was in line with our expectations and commentary last quarter. Looking forward, we expect continued pressure in this market with demand bottoming out in the next one to two quarters. With our new market disclosures, service revenues are counted within our core market verticals. But on a standalone basis, our Q4 service revenue was $26.7 million, down slightly from Q3. For the year, our service revenue grew 2% to $111 million. However, if we exclude the central inverter service business that we sold in May of 2019, revenue grew 7% for the year despite lower factory utilization by our customers.Gross margin for the quarter was 33.2%. Cost of sales included approximately $6.8 million of acquisition-related charges and $2.2 million of facility expansion and relocation costs primarily related to our strategic investment in the Malaysia factory. On a non-GAAP basis, gross margin was 35.9% which is at the high end of our guided range. Gross margins benefited from lower fixed cost absorption on higher revenue and lower warranty cost. Looking to Q1, we expect adjusted gross margins to be in the 34% to 36% range.GAAP operating expenses in Q4 came in at $90 million, including $5.3 million of intangible amortization, $2.6 million of acquisition related charges, $2.1 million of stock compensation and $2.1 million of restructuring and transition expenses. In addition, in Q4, we recorded a one-time reserve of $4.2 million for doubtful accounts related to our exposure in China to certain program delays and business conditions that have been further impacted by the coronavirus. This is reflected in both our GAAP and non-GAAP operating expenses. Non-GAAP operating expenses were $78 million. If we exclude the one-time reserve, our non-GAAP operating expenses came in below the low end of our guidance range on good expense control and initial synergy savings. Looking forward, we expect adjusted operating expenses in the first quarter to be between $73 million and $77 million.GAAP operating margin for the quarter was 6.6%. Non-GAAP operating margin was 12.8%. Non-operating expenses on a GAAP basis came in at $4.8 million. On a non-GAAP basis, non-operating expense was $3.8 million, made up of $2.3 million of net interest expense plus $1.5 million in foreign exchange loss and other items. Looking forward, we expect non-operating expense to run in the $1.5 million to $2 million range.In Q4, we recorded GAAP tax expense of $6.9 million or 40% higher than normal due to non-deductibility of certain transaction costs. Our non-GAAP tax expense was $6.2 million or 16%. Looking forward, we expect our GAAP and a non-GAAP tax rate to be in the range of 16% to 18% with the addition of Artesyn. On a GAAP basis, earnings per diluted share from continuing operations were $0.27 compared to earnings of $0.19 last quarter and $0.50 last year. Non-GAAP EPS for the quarter was $0.87 above the high end of our guidance due to higher revenue, favorable gross margin and good expense management. This compares to $0.54 in the prior quarter and $0.73 a year ago.Turning now to Artesyn, Q4 was the first full quarter of integrating Artesyn and the team has done a great job accelerating our efforts to realize the synergies of this acquisition. As of the end of Q4, we have realized synergies equivalent to over $10 million on an annualized basis. Combined with our strong performance in data center computing, Artesyn was solidly accretive in Q4 adding more than $0.20 per share to our non-GAAP earnings, including the interest expense of financing. While the level of accretion will fluctuate from quarter-to-quarter, we remain confident that we are well on our way to achieve our 18 to 24 month target earnings accretion of over $0.80.Turning now to the balance sheet, operating cash flow from continuing operations was approximately $19 million, which includes several one-time payments related to the Artesyn acquisition. Excluding these one-time payments, operating cash flow was over $45 million. We ended the quarter with cash and marketable securities of $349 million, up $8 million from Q3. Total debt was $339 million after amortization payments on the loan. Receivables decreased slightly and DSO was 66 days. Inventory decreased by $11 million and turns were 3.9 times. Payables decreased to $170 million due to timing of receipts and payments and represents 68 days DPO. Capital expenditures for the quarter were $9.5 million and depreciation was $5.5 million. The higher capital expenditures reflects a full quarter of Artesyn CapEx as well as increased investment related to the new manufacturing facility in Malaysia. During the quarter, we did not repurchase any shares.Now, let me turn to guidance. Looking forward, we continue to see strong demand for our products and expect sequential growth in orders in Q1 led by semiconductor and data center markets. In addition, while visibility is low in the second half, we are encouraged by recent projections for improvement in our markets and believe that overall 2020 will be a solid growth year in both demand and the revenue on an actual and pro forma basis. In the near-term, we expect revenues to be impacted by the challenging environment in China related to coronavirus. As a result, we estimate revenues to be $310 million plus or minus $30 million in Q1. We estimate Q1 non-GAAP earnings at $0.70 per share plus or minus $0.30.Due to the uncertainty created by the novel coronavirus outbreak, we are providing a wider guidance range based on our team’s current assessment of our supply chain, product delivery and production planning. In the near-term, we expect to see some increased costs for expedite fees, transportation and factory utilization as we actively work with our suppliers and customers to mitigate the challenge and fulfill our increasing backlog. As a note, given our China footprint, we expect Artesyn products to be relatively more impacted and to represent just under half our guided Q1 revenue, but to still be accretive to non-GAAP earnings.I want to stress the demand for our products is strong, continues to grow and is above our revenue guidance. Although the coronavirus is disrupting our supply chain in the near-term, we believe continued recovery in our markets, our increased revenue diversity and success in securing additional design wins should mitigate the near-term impact and still enable solid growth year-over-year for 2020. Combined with our efforts to realize synergies, we expect to accelerate earnings growth and improve return on invested capital over time.With that, we will open the call to your questions. Operator?